Dr. Perez Garcia is the Vice President, Translational Sciences at Neogene Therapeutics. She has more than 16 years of combined academic and biopharma industry experience in cancer immunology and immunotherapy research supporting preclinical projects for engineered T cell therapies in oncology. Before joining Neogene, she spent nearly seven years at Kite Pharma, where she led the preclinical development of several CAR and TCR programs, serving most recently as Senior Director, Cell Therapy Research and acting as the research lead for next-generation programs in B-cell malignancies. Dr. Perez Garcia earned a B.S. and a Ph.D. from the University of Barcelona, a Master’s degree in scientific communications from Pompeu Fabra University in Barcelona and completed post-doctoral fellowships at New York University and Columbia University.